Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.39 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | CPT1A | P50416 | 1/20 | 0.33 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid Methyl Ester SCHEMBL27768630 | 0.92 | GPR119 (0.41) | GPR119AOC3EPHA2KDREPHB4 | |
| SCHEMBL1118179 | 0.91 | GPR119 (0.44) | GPR119AOC3EPHA2KDREPHB4 | |
| Hydrochloric Acid SCHEMBL1118214 | 0.90 | GPR119 (0.43) | GPR119AOC3EPHA2KDREPHB4 | |
| SCHEMBL27768127 | 0.88 | GPR119 (0.38) | GPR119AOC3EPHA2KDREPHB4 | |
| Tert-Butyl Formate SCHEMBL27768084 | 0.88 | AOC3 (0.42) | GPR119AOC3EPHA2KDREPHB4 | |
| Tert-Butyl Formate SCHEMBL28781308 | 0.88 | GPR119 (0.44) | GPR119AOC3EPHA2KDREPHB4 | |
| Tert-Butyl Formate SCHEMBL27768122 | 0.88 | GPR119 (0.43) | GPR119AOC3EPHA2KDREPHB4 | |
| Tert-Butyl Formate SCHEMBL27789576 | 0.87 | AOC3 (0.40) | GPR119AOC3EPHA2KDREPHB4 | |
| Acetic Acid SCHEMBL27973962 | 0.87 | GPR119 (0.45) | GPR119AOC3EPHA2KDREPHB4 | |
| SCHEMBL27789528 | 0.86 | GPR119 (0.38) | GPR119AOC3EPHA2KDREPHB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101616586-B | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | CYMABAY THERAPEUTICS INC | 2014-08-13 | — | — | CN | claimed |
| CN-101616586-B | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | CYMABAY THERAPEUTICS INC | 2014-08-13 | — | — | CN | disclosed |
| CN-102026636-B | Oxymethylene aryl compounds and uses thereof | METABOLEX INC | 2014-07-16 | — | — | CN | disclosed |
| CN-102026636-A | Oxymethylene aryl compounds and uses thereof | METABOLEX INC | 2011-04-20 | — | — | CN | disclosed |
| CN-101616586-A | The heterocyclic receptor agonists of treatment diabetes and metabolic disorder | METABOLEX INC | 2009-12-30 | — | — | CN | disclosed |